Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) in the Italian population.
Burden of neurological conditions in Canada.
Accumulation and therapeutic modulation of 6-sulfo LacNAc(+) dendritic cells in multiple sclerosis.
Efficacy and Safety of Daclizumab High Yield Process Versus Interferon β 1a in Patients With Relapsing-Remitting Multiple Sclerosis ((DECIDE))
Onset of psoriasis upon interferon beta treatment in a multiple sclerosis patient.
A novel role for protein tyrosine phosphatase 1B as a positive regulator of neuroinflammation.
Leisure time activities of Iranian patients with multiple sclerosis: a qualitative study.
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis.
Preclinical studies of sex differences: a clinical perspective.
Interferon beta treatment of multiple sclerosis increases serum interleukin-7.
Interferon-ß-related tumefactive brain lesion in a Caucasian patient with neuromyelitis optica and clinical stabilization with tocilizumab.
HLA alleles as biomarkers of high-titre neutralising antibodies to interferon-β therapy in multiple sclerosis.
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes.
Dimethyl fumarate inhibits the expression and function of hypoxia-inducible factor-1α (HIF-1α).
Disease-modifying drugs for multiple sclerosis in pregnancy: A systematic review.
Teriflunomide in multiple sclerosis: Added benefit not proven
Dimethyl fumarate-associated lymphopenia: Risk factors and clinical significance.
Identification of naturally occurring Fatty acids of the myelin sheath that resolve neuroinflammation.
Altered intra- and interregional synchronization in relapsing-remitting multiple sclerosis: a resting-state fMRI study.
Laquinimod in Relapsing-Remitting Multiple Sclerosis
Are changes in gait and balance across the Disease Step Rating Scale in Multiple Sclerosis statistically significant and clinically meaningful?
The absence of 25-hydroxyvitamin D3-1α-hydroxylase potentiates the suppression of EAE in mice by ultraviolet light.
A comparison of phase imaging and quantitative susceptibility mapping in the imaging of multiple sclerosis lesions at ultrahigh field.
Alterations of the optic pathway between unilateral and bilateral optic nerve damage in multiple sclerosis as revealed by the combined use of advanced diffusion kurtosis imaging and visual evoked potentials.
Clinical efficacy assessment in photodamaged skin of 0.5% and 1.0% idebenone.
Pages
« first
‹ previous
…
78
79
80
81
82
83
84
85
86
…
next ›
last »